These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38050005)

  • 21. Altered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis.
    Xu S; Jiemy WF; Boots AMH; Arends S; van Sleen Y; Nienhuis PH; van der Geest KSM; Heeringa P; Brouwer E; Sandovici M
    Arthritis Care Res (Hoboken); 2024 Sep; 76(9):1322-1332. PubMed ID: 38685696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E; Karalilova R; Macchioni P; Ponte C; Conticini E; Cowley S; Tomelleri A; Monti S; Monjo I; Batalov Z; Klinowski G; Falsetti P; Kane DJ; Campochiaro C; Hočevar A
    Ann Rheum Dis; 2024 Feb; 83(3):335-341. PubMed ID: 37932008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica.
    Narváez J; Estrada P; López-Vives L; Ricse M; Zacarías A; Heredia S; Gómez-Vaquero C; Nolla JM
    Semin Arthritis Rheum; 2015 Dec; 45(3):328-33. PubMed ID: 26186807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are polymyalgia rheumatica and giant cell arteritis the same disease?
    Cantini F; Niccoli L; Storri L; Nannini C; Olivieri I; Padula A; Boiardi L; Salvarani C
    Semin Arthritis Rheum; 2004 Apr; 33(5):294-301. PubMed ID: 15079760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
    Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
    Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis.
    Hemmig AK; Aschwanden M; Berger CT; Kyburz D; Mensch N; Staub D; Stegert M; Imfeld S; Daikeler T
    Rheumatology (Oxford); 2024 May; 63(6):1523-1527. PubMed ID: 37647653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan.
    Fukui S; Nunokawa T; Kobayashi S; Kamei S; Yokogawa N; Takizawa Y; Shimada K; Sugii S; Setoguchi K
    Mod Rheumatol; 2016; 26(2):259-64. PubMed ID: 26156043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
    Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
    J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.
    van Sleen Y; Therkildsen P; Nielsen BD; van der Geest KSM; Hansen I; Heeringa P; Posthumus MD; Sandovici M; Toonen EJM; Zijlstra J; Boots AMH; Hauge EM; Brouwer E
    Arthritis Res Ther; 2022 Mar; 24(1):65. PubMed ID: 35255968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
    Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
    J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
    Bartolome MJ; Martínez-Taboda VM; Lopez-Hoyos M; Blanco R; Rodriguez-Valverde V
    Clin Exp Rheumatol; 2001; 19(3):259-64. PubMed ID: 11407077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study.
    Singh JA; Cleveland JD
    Clin Rheumatol; 2020 Nov; 39(11):3427-3438. PubMed ID: 32399772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
    Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
    J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.
    Martinez-Taboada VM; Alvarez L; RuizSoto M; Marin-Vidalled MJ; Lopez-Hoyos M
    Cytokine; 2008 Nov; 44(2):207-20. PubMed ID: 18986814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of giant cell arteritis after prednisolone dose reduction during treatment of polymyalgia rheumatica].
    Yamashita M; Aoki A; Kobayashi H; Wakiya M; Nakatsugawa M
    Nihon Ronen Igakkai Zasshi; 2023; 60(4):440-447. PubMed ID: 38171762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study.
    Paskins Z; Whittle R; Sultan AA; Muller S; Blagojevic-Bucknall M; Helliwell T; Hider S; Roddy E; Mallen C
    BMC Med; 2018 Jan; 16(1):4. PubMed ID: 29316928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review.
    Liozon E; Parreau S; Filloux M; Dumonteil S; Gondran G; Bezanahary H; Ly KH; Fauchais AL
    Autoimmun Rev; 2021 Feb; 20(2):102732. PubMed ID: 33326851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.
    Roche NE; Fulbright JW; Wagner AD; Hunder GG; Goronzy JJ; Weyand CM
    Arthritis Rheum; 1993 Sep; 36(9):1286-94. PubMed ID: 8216422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
    Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
    Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.